Sushen Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 2.95 M
as on 16-11-2024
- Company Age 36 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 24.26%
(FY 2023)
- Ebitda 86.25%
(FY 2023)
- Net Worth -51.28%
(FY 2023)
- Total Assets -0.04%
(FY 2023)
About Sushen Remedies
The Corporate was formerly known as Balaji Suppliers Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.95 M, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Jajoo, Mangla Bangur, and Anand Bangur serve as directors at the Company.
- CIN/LLPIN
U24232MP1988PTC019205
- Company No.
019205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sushen Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnu Jajoo  | Director | 20-Dec-2010 | Current |
| Mangla Bangur | Director | 24-May-2006 | Current |
| Anand Bangur | Director | 20-Feb-1996 | Current |
Financial Performance and Corporate Structure Insights of Sushen Remedies.
Sushen Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sushen Remedies?
In 2023, Sushen Remedies had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shriji Polymers Medical Devices Private LimitedActive 2 years 1 monthVishnu Jajoo and Anand Bangur are mutual person
- Shriji Polymers (India) LimitedActive 28 years 5 months
Vishnu Jajoo and Anand Bangur are mutual person
Four M Propack Private LimitedActive 16 years 4 monthsVishnu Jajoo and Anand Bangur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sushen Remedies?
Unlock and access historical data on people associated with Sushen Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sushen Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushen Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
